GLP-1 Vision Loss (Ozempic / Wegovy NAION)
Published Updated
By People's Justice
What happened
Google Trends data recorded a breakout rise in searches for 'ozempic and vision loss' along with sharp increases in related terms including 'wegovy side effects,' 'mounjaro side effects,' 'tirzepatide side effects,' and 'retatrutide side effects' during the week detected on July 24, 2026.
Event date:
Source: trends.google.com
GLP-1 Vision Loss (Ozempic / Wegovy NAION)
News outlets reported that over 200 federal lawsuits have been filed alleging GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro caused NAION, a rare and often permanent form of vision loss. Manufacturers reportedly dispute the claims, and plaintiffs allege they were not adequately warned of the risk.
Source: yahoo.com
GLP-1 Vision Loss (Ozempic / Wegovy NAION)
The New York Post reported that a man's claim of sudden, permanent blindness after using Ozempic is one of hundreds of lawsuits filed against GLP-1 drug makers alleging inadequate warning of vision loss risk. Separately, a Medical Economics roundup noted reporting that Wegovy may carry a higher risk of 'eye stroke' than other GLP-1 drugs, and a systematic review in the Canadian Journal of Ophthalmology examined a possible link between GLP-1 receptor agonist use and age-related macular degeneration.
Source: news.google.com
GLP-1 Vision Loss (Ozempic / Wegovy NAION)
News reports from the New York Post and other outlets describe hundreds of lawsuits against GLP-1 drug makers, with plaintiffs alleging the drugs were not adequately labeled to warn of potential vision loss. A separate report notes Wegovy may carry a higher risk of 'eye stroke' than other GLP-1 drugs, and a new systematic review examined possible links between GLP-1 receptor agonist use and age-related macular degeneration.
Source: news.google.com